Moderna gets emergency use authorisation for its COVID-19 vaccine in US

Washington, Dec ember 19 : Moderna has become the second company to get emergency use authorisation for its anti-corona virus vaccine from the US Food and Drug Administration (FDA), a week after the one developed by Pfizer received a similar approval. According to an official statement, the FDA has determined that the Moderna COVID-19 vaccine has met the statutory criteria for issuance of an emergency use authorisation (EUA). This vaccine is for people aged 18 or older. “Congratulations, the Moderna vaccine is now available!” President Donald Trump tweeted soon after. An immunisation drive using the vaccine developed by Pfizer has begun in the US earlier this week. Vice President Mike Pence took the shot publicly on Friday. Delivery to the US government will begin immediately. Moderna will continue to gather additional data and plans to file a Biologics License Application (BLA) with the FDA requesting full licensure in 2021, it said. Allocation and distribution of the vaccine will be prioritised according to populations identified by the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP). Approximately 20 million doses will be delivered to the US government by the end of December 2020. The company expects to have between 100 million and 125 million doses available globally in the first quarter of 2021, with 85-100 million of those available in the US, Moderna said.

By: R News India 24